Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Biochemistry

• Publication date

  1980-11-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI00565A001PMID 6257279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological characterization of multiple weight forms of human cell plasminogen activators.

  1979cited by this paper
• Specificity of response in hamster cells induced to produce plasminogen activator by the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate.

  1978cited by this paper
• Serine enzymes released by cultured neoplastic cells

  1978cited by this paper
• Proteolytic Modification of Cell Surface Macromolecules: Mode of Action in Stimulating Cell Growth

  1978cited by this paper
• Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.

  1978cited by this paper
• Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.

  1977cited by this paper
• Purification and properties of a plasminogen activator from pig heart.

  1977cited by this paper
• Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture

  1976cited by this paper
• Purification of urokinase by affinity chromatography.

  1976cited by this paper
• Equilibrium binding of thrombin to platelets.

  1976cited by this paper
• Purification and characterization of two forms of urokinase.

  1976cited by this paper
• Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells

  1976cited by this paper
• Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

  1975cited by this paper
• Effect of proteases on activation of resting chick embryo fibroblasts and on cell surface proteins.

  1975cited by this paper
• Inhibition of protease activity in cultures of rous sarcoma virus-transformed cells: effect on the transformed phenotype.

  1975cited by this paper
• The Inhibition of Urokinase by Aromatic Diamidines

  1975cited by this paper
• Actin-containing cables within anchorage-dependent rat embryo cells are dissociated by plasmin and trypsin

  1975cited by this paper
• Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses.

  1974cited by this paper
• A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

  1974cited by this paper
• Fibrinolysis associated with oncogenic transformation. Morphological correlates.

  1974cited by this paper
• SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES

  1974cited by this paper
• Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

  1974cited by this paper
• Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40.

  1974cited by this paper
• Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

  1974cited by this paper
• Alteration of cell-surface proteins by viral transformation and by proteolysis.

  1973cited by this paper
• FIBRINOLYSIS ASSOCIATED WITH ONCOGENIC TRANSFORMATION

  1973cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSES

  1973cited by this paper
• Fluorometric assay of proteins in the nanogram range.

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The isolation and characterization of plasminogen activators (urokinase) from human urine.

  1966cited by this paper
• The preparation of human fibrinogen free of plasminogen.

  1962cited by this paper
• The control of cellular morphology in embryonic cells infected with rous sarcoma virus in vitro.

  1960cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• plus Ad 2E 1 a ras cHa-but not ras Phenotype : Induction by Transfection with cHa-Secretion of Type IV Collagenolytic Protease and Metastatic

  2006cites this paper
• PLASMINOGEN ACTIVATORS, ACTIVATION INHIBITORS AND AND MALIGNANT HUMAN CELLS ALPHA,-MACROGLOBULIN PRODUCED BY CULTURED NORMAL

  2006cites this paper
• Synthesis and Secretion of Plasminogen Activators and Plasminogen Activator Inhibitors in Cell Lines of Different Groups of Human Lung Tumors1

  2006cites this paper
• Structure and function of human sweat glands studied with histochemistry and cytochemistry.

  2002cites this paper
• Matrix metalloproteinases produced by rat IL-2-activated NK cells.

  1998cites this paper
• Autoactivation of Avian Urokinase-type Plasminogen Activator (uPA)

  1998cites this paper
• IL-2-Activated NK Cells Matrix Metalloproteinases Produced by Rat Albertsson

  1998cites this paper
• Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.

  1997cites this paper
• Avian urokinase-type plasminogen activator (u-PA) lacks the putative binding site for plasminogen activator inhibitor (PAI) and is resistant to inhibition by human PAI-1 and PAI-2*

  1995cites this paper
• Urokinase‐type plasminogen activator in human eccrine sweat

  1993cites this paper
• Kinetic behaviour of zymogen activation processes in the presence of an inhibitor.

  1993cites this paper
• Platinum complexes of p- and m-aminobenzamidine. Synthesis, characterization, and cytotoxic activity.

  1992cites this paper
• Dysregulated proteolysis in AIDS.

  1992cites this paper
• Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.

  1991cites this paper
• The chicken urokinase-type plasminogen activator gene.

  1990cites this paper
• A novel leupeptin-sensitive serine endopeptidase present in normal and malignant rat mammary tissues

  1990cites this paper
• Diisopropylfluorophosphate binding proteins (serine hydrolases) from normal and leukemic hematopoietic cells.

  1990cites this paper
• Serine protease and metallo protease cascade systems involved in pericellular proteolysis.

  1990cites this paper
• Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.

  1989cites this paper
• Medroxyprogesterone acetate, an anti‐cancer and anti‐angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells

  1989cites this paper
• Oncogene Products as Potential Therapeutic Targets for Control of Established Metastatic Disease

  1989cites this paper
• Degradation of extracellular matrix by neuronal proteases.

  1989cites this paper
• Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell function.

  1988cites this paper
• Functional role of specific secreted and cell surface molecules in tumour cell invasion and metastasis.

  1988cites this paper
• Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells.

  1988cites this paper
• Induction of DNA synthesis in isolated nuclei by cytoplasmic factors: inhibition by protease inhibitors.

  1987cites this paper
• Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.

  1987cites this paper
• Plasminogen Activators (Urokinase) Mediate Neovascularization: Possible Role in Tumor Angiogenesis

  1986cites this paper
• An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.

  1986cites this paper
• Proteolytic Enzymes in Cancer Invasion and Metastasis

  1986cites this paper
• Proteolytic Enzymes in Tumor Invasion and Degradation of Host Extracellular Matrices

  1986cites this paper
• Thrombin Cleavage of Extracellular Matrix Proteins

  1986cites this paper
• The fibrinolytic system in man.

  1986cites this paper
• The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants

  1985cites this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cites this paper
• Purification of plasminogen activator from Rous sarcoma virus-infected chick embryo fibroblast culture medium.

  1985cites this paper
• Macrophage Neutral Proteinases Nature, Regulation, and Role

  1985cites this paper
• Plasminogen activators, activation inhibitors and alpha2‐macroglobulin produced by cultured normal and malignant human cells

  1984cites this paper
• Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.

  1984cites this paper
• Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture.

  1984cites this paper
• Role of bacterial lipopolysaccharide and lymphokine in the regulation of macrophage activation: correlates between secretion of plasminogen activator and tumor lysis.

  1984cites this paper
• Production of plasminogen activator by human natural killer cells. Large granular lymphocytes

  1984cites this paper
• Mechanism of the Stimulatory Effect of Phorbol 12-Myristate 13-Acetate on Cellular Production of Plasminogen Activator

  1984cites this paper
• Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator.

  1983cites this paper
• A proenzyme from chicken plasma similar to human plasma prekallikrein.

  1983cites this paper
• Production of three plasminogen activators and an inhibitor in keratinocyte cultures.

  1983cites this paper
• [Methods of derivation and physico-chemical properties of plasminogen activators].

  1983cites this paper
• Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator.

  1983cites this paper
• Action of epidermal growth factor and retinoids on anchorage-dependent and -independent growth of nontransformed rat kidney cells.

  1983cites this paper
• Chapter 26. Plasminogen Activators

  1983cites this paper
• Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts.

  1983cites this paper
• Mechanism of tumor cell lysis by natural killer cells.

  1982cites this paper
• Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

  1982cites this paper
• Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase.

  1982cites this paper
• THE ROLE OF NEUTRAL SERINE PROTEASES IN THE MECHANISM OF TUMOR CELL LYSIS BY HUMAN NATURAL KILLER CELLS

  1982cites this paper
• Detection, identification, and partial characterization of serine proteases and esterases in biological systems.

  1982cites this paper
• Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.

  1982cites this paper
• Mechanisms of Tumor Cell Lysis by Natural Killer Cells

  1982cites this paper
• Proteases in tumor invasion and metastasis

  1982cites this paper
• Enhancement of plasminogen activator activity by the culture medium of Rous sarcoma virus-transformed cells.

  1982cites this paper
• Immunological identification and comparison of plasminogen activator forms in cultured normal human endothelial cells and smooth muscle cells.

  1981cites this paper
• Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

  1981cites this paper
• Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin.

  1981cites this paper
• Inhibition of plasminogen activator release from transformed chicken fibroblasts by a protease inhibitor.

  1981cites this paper